The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback